OncoAssure Attending ASCO GU Cancer Symposium 2023

OncoAssure’s CEO, Des O Leary, will attend the ASCO Genitourinary Cancer Symposium held in San Francisco on Feb. 16th to 18 , where the results of the Clinical Validation of the OncoAssure Prostate Test will be presented.

Abstract Number # 374

Poster Bd # N12

Development and clinical validation of a novel biopsy-based six-gene signature to accurately risk-stratify men with early-stage prostate cancer to aid treatment decision making.

J Clin Oncol 41, 2023 (suppl 6; abstr 374), DOI: 10.1200/JCO.2023.41.6_suppl.374